Jazz Pharmaceuticals (JAZZ) EBT Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Jazz Pharmaceuticals | 14.35 Bn | 12.51 Bn | 934.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 566.00 |
| Dec 31, 2025 | -436.00 |
| Sep 30, 2025 | -2,718.00 |
| Jun 30, 2025 | -10,082.00 |
| Mar 31, 2025 | 2,691.00 |
| Dec 31, 2024 | 523.00 |
| Sep 30, 2024 | -221.00 |
| Jun 30, 2024 | -2,100.00 |
| Mar 31, 2024 | -2,285.00 |
| Dec 31, 2023 | -2,865.00 |
| Sep 30, 2023 | -2,579.00 |
| Jun 30, 2023 | -1,732.00 |
| Mar 31, 2023 | -855.00 |
| Dec 31, 2022 | -6,223.00 |
| Sep 30, 2022 | -2,218.00 |
| Jun 30, 2022 | -3,358.00 |
| Mar 31, 2022 | -3,002.00 |
| Dec 31, 2021 | -4,315.00 |
| Sep 30, 2021 | -3,917.00 |
| Jun 30, 2021 | -5,919.00 |
| Mar 31, 2021 | -985.00 |
| Dec 31, 2020 | -655.00 |
| Sep 30, 2020 | -661.00 |
| Jun 30, 2020 | -510.00 |
| Mar 31, 2020 | -7,236.00 |
| Dec 31, 2019 | -2,811.00 |
| Sep 30, 2019 | 494.00 |
| Jun 30, 2019 | 1,286.00 |
| Mar 31, 2019 | 5,370.00 |
| Sep 30, 2018 | -435.00 |
| Jun 30, 2018 | -573.00 |
| Mar 31, 2018 | -1,639.00 |
| Dec 31, 2017 | -402.00 |
| Sep 30, 2017 | -1,067.00 |
| Jun 30, 2017 | 548.00 |
| Mar 31, 2017 | -407.00 |
| Dec 31, 2016 | -671.00 |
| Sep 30, 2016 | -1,388.00 |
| Jun 30, 2016 | -1,123.00 |
| Mar 31, 2016 | -1,071.00 |
| Dec 31, 2015 | 1,230.00 |
| Sep 30, 2015 | 1,652.00 |
| Jun 30, 2015 | 1,958.00 |